The gvhd Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the gvhd Hub cannot guarantee the accuracy of translated content. The gvhd and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View gvhd content recommended for you
The diagnostic yield of endoscopy combined with tissue sampling in gastrointestinal graft-versus-host disease
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently the most effective treatment option for hematological malignancies. Although supportive care for allo-HSCT has improved in recent years, graft-versus-host disease (GvHD) is still a severe, life threatening complication after transplantation. GvHD of the gastrointestinal tract (GI GvHD) can cause inferior mortality rates as well as worsen the patient’s systemic status, thus ensuring prompt diagnosis is mandatory.
To date, the optimal endoscopic approach is debated for GI GvHD patients, therefore Fady Daniel and colleagues compared the diagnostic yield of different anatomic site biopsies in the diagnosis of GI GvHD and evaluated the association between endoscopic findings and histopathology. The findings of this retrospective study were reported in Current Research in Translational Medicine.
Patients and methods
- Study group: n = 19 patients with GI GvHD (median age = 41 years; range, 22–60 years)
- Control group: n = 25 patients
- Biopsies were collected from the American University of Beirut Medical Center (AUBMC) database
Key findings
- The most common presenting symptom in 18/19 patients was severe diarrhea (94.7%), whilst upper gastrointestinal symptoms such as nausea and vomiting were observed in 5/19 patients (26.3%), 3/19 patients had a history of skin GvHD (15.8%)
- Infectious causes of the diarrhea were not included such as Clostridium difficile infection
- 17/19 patients were CMV seropositive (two recipient patients’ CMV status is unknown)
- Combined upper endoscopy and sigmoidoscopy with biopsies showed the highest diagnostic yield in comparison with upper endoscopy, sigmoidoscopy and colonoscopy: 90% versus6%, 78.6% and 77.8%, respectively
- The recto-sigmoid and duodenal biopsies had the highest diagnostic yield regarding macroscopically normal mucosa: 75%
- Macroscopically abnormal mucosa biopsy had the highest yield in terms of recto-sigmoid biopsies (100%) in lower endoscopy, and duodenal biopsies in the upper endoscopy (60%)
Taken together, these results provide evidence that currently, the best endoscopic approach is the combination of upper endoscopy and flexible sigmoidoscopy with biopsies of normal and abnormal mucosa. The authors stated that “it should be emphasized that normal mucosa be biopsied especially in the duodenum and recto-sigmoid for a better diagnostic yield. All patients with suspected GI GvHD should be evaluated by endoscopy and tissue sampling.”
References